Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia

Haematologica

Volumn 87, Issue 11, 2002, Pages 1180-1184

  Randi, Maria Luigia ^b   Fabris, Fabrizio ^a   Ruzzon, Elisabetta ^a   Pacquola, Enrica ^a   Cella, Giuseppe ^a   Girolami, Antonio ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Ospedale 105   (Italy)

Author keywords

Essential thrombocythemia; Polycythemia vera; Splenectomy

Indexed keywords

HEPARIN; WARFARIN;

ADULT; AGE; ARTICLE; BLEEDING; BONE MARROW APLASIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; EVALUATION; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GENDER; HUMAN; INFECTION; LEUKEMIA; MALE; MORTALITY; POLYCYTHEMIA; POPULATION; PORTAL VEIN THROMBOSIS; SPLENECTOMY; STROKE; SURVIVAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLYCYTHEMIA VERA; PORTAL VEIN; RETROSPECTIVE STUDIES; SPLENECTOMY; SURVIVAL ANALYSIS; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOSIS;

EID: 6444244626     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Najean Y, Arrago, JP, Rain JD, Dresch C. The "spent" phase of polycythemia vera: Hypersplenism in the absence of myelofibrosis. Br J Haematol 1984; 56:163-70.
2. Randi ML, Fabris F, Girolami A. Leukemia and myelodysplasia in patients with essential thrombocythemia treated with cytotoxic agents. Haematologica 1999; 84:1049-50.
3. Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997; 34:29-39.
4. Anonymous. Polycythemia vera: The natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia. Ann Intern Med 1995; 123:656-64.
5. Valla D, Benhamou JP. Obstruction of the hepatic veins or suprahepatic inferior vena cava. Dig Dis 1996; 14:99-118.
6. Randi ML, Rossi C, Barbone E, Casonato A, Fabris F, Girolami A. Superior sagittal sinus thrombosis in 5 patients with essential thrombocythemia: A possible disease variant. Rev Iberoam Thromb Hemost 1994; 7:76-8.
7. Tefferi A, Mesa RA, Nagorney DM, Schroeder G, Silverstein MN. Splenectomy in myelofibrosis with myeloid metaplasia: A single-institution experience with 223 patients. Blood 2000; 95:2226-3.
8. Barosi G, Ambrosetti A, Buratti A, Finelli C, Liberato NL, Quaglini S, et al. Splenectomy for patients with myelofibrosis with myeloid metaplasia: Pretreatment variables and outcome prediction. Leukemia 1993; 7:200-6.
9. Berlin NI. Diagnosis and classification of the polycythemias. Semin Hematol 1975; 12:339-51.
10. Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thrombocythemia: An interim report from the Polycythemia Vera Study Group. Semin Hematol 1986; 23:177-82.
11. Randi ML, Rossi C, Tison T, Barbone E, Girolami A. Portal thrombosis and myeloproliferative diseases. Int Congress Phlebolymphology 1991; 21.1-21.3 [abstract].
12. Valla D, Casadevall N, Huisse MG, Tulliez M, Grange JD, Muller O, et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology 1988; 94:1063-9.
13. Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, et al. Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy. Gastroenterology 2001; 120:490-7.
14. Randi ML, Stocco F, Rossi C, Tison T, Girolami A. Thrombosis and hemorrhage in thrombocytosis: Evaluation of a large cohort of patients (357 cases). J Med 1991; 22:213-33.
15. Higuchi T, Okada S, Mori H, Niikura H, Omine M, Terada H. Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agent. Cancer 1995; 75:471-7.
16. Barosi G, Ambrosetti A, Centra A, Falcone A, Finelli C, Foa P, et al. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myelofibrosis with Myeloid Metaplasia. Blood 1998; 91:3630-6.
17. van't Riet M, Burger JW, van Muiswinkel JM, Kazemier G, Schipperus MR, Bonjer HJ. Diagnosis and treatment of portal vein thrombosis following splenectomy. Br J Surg 2000; 87:1229-33.
18. Cortelazzo S, Viero P, Finazzi G, D'Emilio A, Rodeghiero F, Barbui T. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 1990; 8:556-62.